Annals of the Rheumatic Diseases, ‎0003-4967

Journal

Publications

  1. 2021
  2. Accepted/In press

    EULAR points to consider for conducting clinical trials and observational studies in individuals at-risk of rheumatoid arthritis

    Karim Raza, , , , & , 24 Jul 2021, (Accepted/In press) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journalArticlepeer-review

  3. Published
  4. 2020
  5. Published
  6. Published
  7. Published
  8. Published
  9. Accepted/In press

    Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

    Lorraine Harper, Apr 2020, (Accepted/In press) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journalArticlepeer-review

  10. Published
  11. Accepted/In press
  12. Published

    Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care

    Raymond Oppong, , , , , , , Sue Jowett, , , , , , , & , Feb 2020, In: Annals of the Rheumatic Diseases. 79, 2, p. 276-284 9 p.

    Research output: Contribution to journalArticlepeer-review

  13. Published

    EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies

    Benjamin Fisher & 2 others, Simon Bowman & , Jan 2020, In: Annals of the Rheumatic Diseases. 79, 1, p. 3-18 16 p., 216114.

    Research output: Contribution to journalArticlepeer-review

  14. 2019
  15. Published

    Urine metabolic profile in rheumatoid arthritis development

    Stephen Young & , 27 Jun 2019, In: Annals of the Rheumatic Diseases. 78, Suppl 2, p. 2129-2130 2 p.

    Research output: Contribution to journalAbstractpeer-review

  16. Published

    2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

    Caroline Gordon, 29 Mar 2019, In: Annals of the Rheumatic Diseases. 78, 6, p. 736-745 10 p.

    Research output: Contribution to journalReview articlepeer-review

  17. Published
  18. Published
  19. Published

    Current challenges in the development of new treatments for lupus

    Caroline Gordon, , & , 12 Jan 2019, In: Annals of the Rheumatic Diseases. 78, 6, p. 729-735 7 p.

    Research output: Contribution to journalArticlepeer-review

  20. Published
  21. 2018
  22. Published
  23. E-pub ahead of print

    Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?

    Jennifer Marshall, , , , , Ilfita Sahbudin, , , , , , Karim Raza, Andrew Filer, Christopher Buckley, & , 14 Dec 2018, (E-pub ahead of print) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journalArticlepeer-review

  24. E-pub ahead of print

    Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis

    Adam Croft, , , , , , , Christopher Buckley, , , & , 30 Jul 2018, (E-pub ahead of print) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journalArticlepeer-review

  25. Published
  26. E-pub ahead of print
  27. Published
  28. Published
  29. E-pub ahead of print
  30. 2017
  31. Published
  32. E-pub ahead of print

    Antibodies against collagen type II are not a general marker of acute arthritis onset

    Andrew Filer, Karim Raza & , 24 Aug 2017, (E-pub ahead of print) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journalLetterpeer-review

  33. Published

    Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren’s syndrome

    Jul 2017, In: Annals of the Rheumatic Diseases. 76, 7, p. 1161-1168 8 p.

    Research output: Contribution to journalArticlepeer-review

  34. Published
  35. Published
  36. Published
  37. Published

    EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis

    Karim Raza, 1 Mar 2017, In: Annals of the Rheumatic Diseases. 76, 3, p. 491-496 6 p.

    Research output: Contribution to journalArticlepeer-review

  38. Published
  39. 2016
  40. E-pub ahead of print

    2016 update of the EULAR recommendations for the management of early arthritis

    Karim Raza, 15 Dec 2016, (E-pub ahead of print) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journalArticlepeer-review

  41. Published
  42. Published

    MICL controls inflammation in rheumatoid arthritis

    Rebecca Drummond, , , , , , , , , , , , , & , 1 Jul 2016, In: Annals of the Rheumatic Diseases. 75, 7, p. 1386-1391 6 p.

    Research output: Contribution to journalArticlepeer-review

  43. Published
  44. Published
  45. Published
  46. 2015
  47. Published
  48. Published
  49. Published

    Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

    Matthew Morgan, , Caroline Savage, , , , , , & , Jun 2015, In: Annals of the Rheumatic Diseases. 74, 6, p. 1178-82 5 p.

    Research output: Contribution to journalArticlepeer-review

  50. Published

    The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?

    Karim Raza & Andrew Filer, 1 May 2015, In: Annals of the Rheumatic Diseases. 74, 5, p. 793-794

    Research output: Contribution to journalEditorialpeer-review

  51. Published
  52. Published

    Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials

    Lorraine Harper, , , , & , Jan 2015, In: Annals of the Rheumatic Diseases. 74, 1, p. 177-84 8 p.

    Research output: Contribution to journalArticlepeer-review

  53. Published
  54. Published
  55. 2014
  56. Published
  57. Published
  58. Published
Previous 1 2 3 4 Next